These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 5288356)

  • 21. Heterogeneous activity of rodent and lagomorph parotid gland extracts on the hemocoagulation process.
    Menghi G; Lai G; Piciotti D
    Cell Mol Biol; 1989; 35(5):495-502. PubMed ID: 2611836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The history of phenotypic testing in thrombosis and hemostasis.
    Tripodi A
    Semin Thromb Hemost; 2008 Oct; 34(7):585-92. PubMed ID: 19085759
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TOXIC THROMBOPLASTIC EXTRACTS OF SKIN. POTENTIAL ROLE IN THERMAL INJURY.
    FOX CL; HOLDER IA; MALIN LL
    JAMA; 1964 Feb; 187():655-8. PubMed ID: 14088447
    [No Abstract]   [Full Text] [Related]  

  • 24. [Thromboplastic activity of chronic granulocytic leukemia granulocytes].
    Lisiewicz J; Malkiewicz-Wasowicz B; Biernacka B
    Przegl Lek; 1973; 30(4):367-71. PubMed ID: 4514328
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of coagulation factor deficiency on plasma coagulation kinetics determined via thrombelastography: critical roles of fibrinogen and factors II, VII, X and XII.
    Nielsen VG; Cohen BM; Cohen E
    Acta Anaesthesiol Scand; 2005 Feb; 49(2):222-31. PubMed ID: 15715625
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of various laboratory tests in the control of anticoagulant therapy].
    Molinas FC; Sanchez Avalos JC
    Medicina (B Aires); 1967; 27(2):107-15. PubMed ID: 5600645
    [No Abstract]   [Full Text] [Related]  

  • 27. Inhibition of extrinsic hemostasis activation by low-molecular-weight heparin.
    Stief TW
    Blood Coagul Fibrinolysis; 2006 Nov; 17(8):633-7. PubMed ID: 17102649
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thromboelastographic studies with low-dose heparin.
    Sagar S; Beckett P
    J R Coll Surg Edinb; 1975 Nov; 20(6):391-7. PubMed ID: 1104822
    [No Abstract]   [Full Text] [Related]  

  • 29. Simplification of the concept of coagulation by revival of the inhibitor theory.
    Mann FD
    Thromb Diath Haemorrh; 1970 Feb; 23(1):12-8. PubMed ID: 5420425
    [No Abstract]   [Full Text] [Related]  

  • 30. The extrinsic coagulation activity assay.
    Stief TW; Wieczerzak A; Renz H
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):303-18. PubMed ID: 18586682
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The thrombin activation pathway modulates the assembly, structure and lysis of human plasma clots in vitro.
    Torbet J
    Thromb Haemost; 1995 May; 73(5):785-92. PubMed ID: 7482404
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Mechanisms of heparin resistance and their clinical significance].
    Barkagan ZS; Lychev VG; Bishevskiĭ KM; Tsyvkina LP; Glazunova GA
    Ter Arkh; 1982; 54(8):77-82. PubMed ID: 6753220
    [No Abstract]   [Full Text] [Related]  

  • 33. Protamine enhances fibrinolysis by decreasing clot strength: role of tissue factor-initiated thrombin generation.
    Nielsen VG
    Ann Thorac Surg; 2006 May; 81(5):1720-7. PubMed ID: 16631662
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Present state of heparin therapy].
    Blatrix C; Soulier JP; Vacheron A; Cornu P
    Presse Med (1893); 1969 Mar; 77(15):553-6. PubMed ID: 5796027
    [No Abstract]   [Full Text] [Related]  

  • 35. Heparanase modulates heparinoids anticoagulant activities via non-enzymatic mechanisms.
    Katz BZ; Muhl L; Zwang E; Ilan N; Herishanu Y; Deutsch V; Naparstek E; Vlodavsky I; Preissner KT
    Thromb Haemost; 2007 Dec; 98(6):1193-9. PubMed ID: 18064313
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of thrombelastography with common coagulation tests.
    Zuckerman L; Cohen E; Vagher JP; Woodward E; Caprini JA
    Thromb Haemost; 1981 Dec; 46(4):752-6. PubMed ID: 7330829
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Thrombodynamographic aspects of chronic myeloid leukosis].
    Baran E; Baran T; Niculescu M; Vacariu O
    Rev Med Chir Soc Med Nat Iasi; 1971; 75(2):331-6. PubMed ID: 5284414
    [No Abstract]   [Full Text] [Related]  

  • 38. Another point of view on the mechanism of thrombin generation during cardiopulmonary bypass: role of tissue factor pathway inhibitor.
    Kojima T; Gando S; Kemmotsu O; Mashio H; Goda Y; Kawahigashi H; Watanabe N
    J Cardiothorac Vasc Anesth; 2001 Feb; 15(1):60-4. PubMed ID: 11254842
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of blood coagulation in bullous pemphigoid: role of eosinophils, and local and systemic implications.
    Marzano AV; Tedeschi A; Fanoni D; Bonanni E; Venegoni L; Berti E; Cugno M
    Br J Dermatol; 2009 Feb; 160(2):266-72. PubMed ID: 18945300
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thrombin-activated thrombelastography for evaluation of thrombin interaction with thrombin inhibitors.
    Taketomi T; Szlam F; Vinten-Johansen J; Levy JH; Tanaka KA
    Blood Coagul Fibrinolysis; 2007 Dec; 18(8):761-7. PubMed ID: 17982317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.